April 2014
Volume 55, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2014
MICROPULSE DIODE LASER TRABECULOPLASTY RESULTS IN TREATMENT OF PRIMARY OPEN-ANGLE GLAUCOMA PATIENTS.
Author Affiliations & Notes
  • Enyr Saran Arcieri
    Ophthalmology, Presidente Antônio Carlos University (UNIPAC), Araguar, Brazil
    Ophthalmology, Federal University of Uberlandia (UFU), Uberlandia, Brazil
  • Rafael Saran Arcieri
    Ophthalmology, School of Medicine of Ribeirao Preto, University of Sao Paulo (USP), Ribeirao Preto, Brazil
  • Footnotes
    Commercial Relationships Enyr Arcieri, None; Rafael Arcieri, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science April 2014, Vol.55, 6165. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Enyr Saran Arcieri, Rafael Saran Arcieri; MICROPULSE DIODE LASER TRABECULOPLASTY RESULTS IN TREATMENT OF PRIMARY OPEN-ANGLE GLAUCOMA PATIENTS.. Invest. Ophthalmol. Vis. Sci. 2014;55(13):6165.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: To evaluate the outcome of 360° micropulse diode laser trabeculoplasty (MDLT) in patients with primary open angle glaucoma (POAG).

Methods: Retrospective review of 14 eyes of 14 patients with POAG that underwent MDLT either to achieve a better control of intraocular pressure (IOP) or to reduce the number of eyedrops for IOP control. Each eye underwent 360° MDLT (532 nm wavelength, 1000 mW power, 300 msec duration, 15% duty cicle, 300 µm diameter per spot). Patients were followed for at least 3 months. The intraocular pressure (IOP) was measured at baseline and at 1 month and 3months post-treatment. After treatment, the patients were maintained on their pre-treatment drug regimen until the 1 month visit.

Results: Mean age of the patients was 53.28 ± 6.74 years (44 - 62 years). Mean baseline IOP was 16.6 ± 2 mmHg. IOP significantly decreased at 30 days post MDLT (14.5 ± 1.6 mmHg; p < 0.0004) and maintained similar values at 90 days after treatment (14.6 ± 1.8 mmHg; p < 0.0009). At baseline, the mean number of medication was 1.71 ± 0.72 and 90 days after MDLT it was 1.14 ± 0.53 (p=0.002). Seven patients had a reduction in the number of eyedrops to control IOP. Four patients did not respond to treatment. There were no intra- or post-operative complications caused by MDLT. No pain or side effect was reported.

Conclusions: Our results suggest that 360° MDLT can be a safe and effective treatment option in patients with POAG.

Keywords: 578 laser • 568 intraocular pressure • 633 outflow: trabecular meshwork  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×